Company Filing History:
Years Active: 1989
Title: Shogo Kurasawa: Innovator in Anti-Tumor Compounds
Introduction
Shogo Kurasawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of microbiology and medicinal chemistry. His work focuses on developing novel compounds with potential therapeutic applications.
Latest Patents
Kurasawa holds a patent for a compound known as Bisucaberin. This innovative compound exhibits anti-tumor activity and is characterized as 1,12-dihydroxy-1,6,12,17-tetraazacyclodocosan-2,5,13,16-tetrone. It is produced microbiologically by culturing a microorganism from the genus Alteromonas, specifically Alteromonas haloplanktis SB-1123. The patent details the characterization data of the compound and the microbiological properties of the microorganism. Additionally, the results of in vitro assays demonstrate the anti-tumor activity of Bisucaberin against L-1210 and IMC carcinoma cells.
Career Highlights
Kurasawa is affiliated with the Microbial Chemistry Research Foundation, where he continues to advance his research. His work has garnered attention for its potential impact on cancer treatment and microbiological applications.
Collaborations
Kurasawa collaborates with esteemed colleagues, including Yoshiro Okami and Toshiyuki Kamayama. Their combined expertise enhances the research efforts at the Microbial Chemistry Research Foundation.
Conclusion
Shogo Kurasawa's innovative work in developing Bisucaberin highlights his contributions to anti-tumor research. His dedication to advancing medicinal chemistry is evident through his patent and collaborations.